EV-Mimetics & Drug Delivery
Loading and engineering EV-mimetics as biocompatible targeted vehicles.
We are developing novel and scalable engineering methods applicable to EVs and EV-mimetics to create actively targeted drug delivery vehicles.
Our proprietary methods allow for the scalable and rapid synthesis of cell-membrane-derived EV-mimicking nanoparticles. We aim to utilize these vehicles to deliver small non-coding genetic material, proteins, and standard chemotherapies directly to primary and metastatic breast cancer cells.